Bioequivalence and Adhesion Comparison of Buprenorphine Patches
Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
To compare a 2nd generation Buprenorphine Transdermal System (BTDS) patch with a marketed 1st
generation BTDS patch to confirm that the two are bioequivalent (deliver the same amount of
drug) and that they equally both stick to the skin over 7 days of continuous wear.